Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Pediatrics · Beta-Ketothiolase Deficiency

Understanding Your Child's Diagnosis of Beta-Ketothiolase Deficiency

At a Glance

Beta-ketothiolase deficiency is a rare inherited disorder in which a child cannot properly process certain protein products and ketones. Avoiding fasting and starting high-carbohydrate fluids during illness, according to the metabolic team's plan, helps reduce the risk of dangerous ketoacidosis.

The transition from having an apparently healthy child to managing a rare genetic condition like Beta-Ketothiolase Deficiency (BKTD) is often sudden and traumatic. For many families, the diagnosis follows a terrifying emergency room visit where a simple childhood illness—like a cold or stomach bug—spirals into a life-threatening crisis [1][2].

It is normal to feel overwhelmed, disoriented, and anxious. Understanding the mechanics of the condition and the path ahead is the first step in moving from crisis to confident management.

What is Beta-Ketothiolase Deficiency?

Beta-Ketothiolase Deficiency (also known as MATD or T2 deficiency) is a rare inherited metabolic disorder. In plain language, your child’s body lacks a specific “worker” (the T2 enzyme) responsible for two critical jobs [3]:

  1. Protein Breakdown: It helps break down isoleucine, one of the building blocks (amino acids) found in the protein we eat. Without enough T2 enzyme, toxic byproducts from this process can build up in the blood [4].
  2. Using Ketones for Energy: When the body runs low on sugar (glucose)—such as during a fast or an illness—it normally burns fat to create ketones for fuel. The T2 enzyme is needed to process these ketones. When it isn’t working, ketones accumulate to dangerously high levels, a state called ketoacidosis [1][5].

The “Unexpected Crisis”

For most families, the first sign of BKTD appears when a child is between 6 and 24 months old, with a median age of 12 months [1]. Before this, many children appear completely healthy and may have even passed their newborn screenings, as some screening tests can miss the condition when a baby is stable [6][7].

The crisis is usually triggered by “metabolic stress,” such as:

  • A common viral infection (fever, vomiting, or diarrhea) [1].
  • Prolonged fasting (going too long without eating) [5].
  • Exceeding prescribed dietary limits in some cases [8].

During these times, the body’s demand for energy increases, and the failure to process ketones lead to rapid, deep breathing (tachypnea), extreme sleepiness (lethargy), and severe vomiting [1][2].

How Rare is This Condition?

BKTD is exceptionally rare, though exactly how rare depends on your family’s geographic and ethnic background. Available population estimates are cohort-specific (meaning they vary based on who was studied and the screening methods used):

  • China: An estimate of 1 in 1,000,000 newborns based on a large screening study [9].
  • Vietnam: An estimate of 1 in 190,000 newborns in a northern cohort [2].
  • Other Regions: Some smaller pilot studies have identified varied rates, such as 1 confirmed case among 25,276 screened newborns in an Egyptian cohort [10]. Note that these numbers do not predict your individual child’s prognosis.

Because it is an autosomal recessive condition, both parents must be carriers of a variant in the ACAT1 gene for a child to be affected [11]. Carriers themselves typically have no symptoms and may never know they carry the gene until a child is diagnosed [12]. Each pregnancy between two carriers has a 25% chance of the child having the condition.

Life Between Episodes

One of the most disorienting aspects of BKTD is that between metabolic crises, most children are completely healthy and meet all their developmental milestones [1]. In a review of 244 patients, 77% of those with reported outcomes showed normal psychomotor development and no neurological issues [1].

Because your child looks and acts “fine” most of the time, it can be easy for others—like relatives or daycare providers—to underestimate the seriousness of the condition. Maintaining a strict management plan is essential, even when your child is thriving.

Managing the Condition: Consensus vs. Debate

Because BKTD is so rare, your medical team will tailor a plan specifically for your child. However, there are areas where doctors generally agree and others where there is ongoing discussion:

Strong Medical Consensus:

  • Avoid Fasting: This is the most critical rule. Your child’s body must never be forced to rely solely on ketones for energy. Your doctor will provide a “safe fasting duration” based on your child’s age [5][8].
  • Early Glucose During Illness: At the first sign of illness or poor appetite, the goal is to provide high-carbohydrate liquids (sugar) to prevent the body from entering a “catabolic state” (breaking down its own fat and muscle) [5][13].

Areas of Individualized Care:

  • Protein Restriction: While some centers recommend a mildly low-protein diet to limit isoleucine intake, others do not believe strict restriction is always necessary to prevent crises [8][14].
  • Supplements: Some children are prescribed L-carnitine, a supplement that helps the body process fats, though its use depends entirely on the child’s specific labs and the clinic’s protocols [15][16].

Your metabolic team will help you navigate these choices, using blood and urine tests to monitor how your child’s body is responding to their specific management plan [17].

Common questions in this guide

What is beta-ketothiolase deficiency in children?
Beta-ketothiolase deficiency is a rare inherited metabolic disorder involving the T2 enzyme. The enzyme helps process isoleucine from protein and ketones used for energy, so illness or fasting can cause dangerous ketoacidosis.
What can trigger a metabolic crisis in a child with BKTD?
Common triggers include viral illness, fever, vomiting, diarrhea, poor appetite, and going too long without food. In some children, exceeding prescribed dietary limits may also contribute to a crisis.
Why is fasting dangerous for a child with beta-ketothiolase deficiency?
During fasting, the body burns fat and produces ketones for energy. A child with BKTD cannot process ketones normally, so they can build up and cause ketoacidosis; the metabolic team should set the child's safe fasting limit.
What should I do if my child with BKTD becomes sick or will not eat?
Follow the individualized illness plan from your child's metabolic team and contact the team promptly if symptoms or poor intake develop. The plan may call for high-carbohydrate liquids early in the illness to provide glucose and reduce the risk of a metabolic crisis.
Can children with beta-ketothiolase deficiency develop normally between episodes?
Many children with BKTD are healthy between metabolic crises and meet their developmental milestones. Outcomes vary, so regular follow-up with the child's medical team remains important even when the child appears well.
How is beta-ketothiolase deficiency inherited?
BKTD is inherited in an autosomal recessive pattern, meaning a child usually receives an ACAT1 variant from each parent. When both parents are carriers, each pregnancy has a 25% chance of being affected.
Do all children with BKTD need a low-protein diet or L-carnitine?
Not necessarily. Some centers recommend mild protein restriction, while others do not use strict restriction, and L-carnitine is prescribed for some children based on laboratory results and the clinic's protocol.

Get notified when new evidence is published on 2-methylacetoacetyl CoA thiolase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    2-methylacetoacetyl-coenzyme A thiolase (beta-ketothiolase) deficiency: one disease - two pathways.

    Grünert SC, Sass JO

    Orphanet journal of rare diseases 2020; (15(1)):106 doi:10.1186/s13023-020-01357-0.

    PMID: 32345314
  2. 2

    Characterization and outcome of 41 patients with beta-ketothiolase deficiency: 10 years' experience of a medical center in northern Vietnam.

    Nguyen KN, Abdelkreem E, Colombo R, et al.

    Journal of inherited metabolic disease 2017; (40(3)):395-401 doi:10.1007/s10545-017-0026-6.

    PMID: 28220263
  3. 3

    The recent insights into the function of ACAT1: A possible anti-cancer therapeutic target.

    Goudarzi A

    Life sciences 2019; (232()):116592 doi:10.1016/j.lfs.2019.116592.

    PMID: 31228515
  4. 4

    Clinical and Mutational Characterizations of Ten Indian Patients with Beta-Ketothiolase Deficiency.

    Abdelkreem E, Akella RRD, Dave U, et al.

    JIMD reports 2017; (35()):59-65 doi:10.1007/8904_2016_26.

    PMID: 27928777
  5. 5

    Inborn errors of ketone body utilization.

    Hori T, Yamaguchi S, Shinkaku H, et al.

    Pediatrics international : official journal of the Japan Pediatric Society 2015; (57(1)):41-8 doi:10.1111/ped.12585.

    PMID: 25559898
  6. 6

    Recent advances in understanding beta-ketothiolase (mitochondrial acetoacetyl-CoA thiolase, T2) deficiency.

    Fukao T, Sasai H, Aoyama Y, et al.

    Journal of human genetics 2019; (64(2)):99-111 doi:10.1038/s10038-018-0524-x.

    PMID: 30393371
  7. 7

    Mutation update on ACAT1 variants associated with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency.

    Abdelkreem E, Harijan RK, Yamaguchi S, et al.

    Human mutation 2019; (40(10)):1641-1663 doi:10.1002/humu.23831.

    PMID: 31268215
  8. 8

    Analysis of the clinical phenotype and genotype features of 5 cases of beta-ketothiolase deficiency.

    Jin JL, Wu D, Ding Y

    BMC pediatrics 2026; (26(1)).

    PMID: 41639795
  9. 9

    C4OH is a potential newborn screening marker-a multicenter retrospective study of patients with beta-ketothiolase deficiency in China.

    Lin Y, Yang Z, Yang C, et al.

    Orphanet journal of rare diseases 2021; (16(1)):224 doi:10.1186/s13023-021-01859-5.

    PMID: 34001203
  10. 10

    Inborn errors of metabolism detectable by tandem mass spectrometry in Egypt: The first newborn screening pilot study.

    Hassan FA, El-Mougy F, Sharaf SA, et al.

    Journal of medical screening 2016; (23(3)):124-9 doi:10.1177/0969141315618229.

    PMID: 26790708
  11. 11

    Identification of two novel ACAT1 variant associated with beta-ketothiolase deficiency in a 9-month-old boy.

    Wang Y, Gao Q, Wang W, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2022; (35(9)):1194-1200 doi:10.1515/jpem-2022-0158.

    PMID: 35850931
  12. 12

    A Novel Mutation of Beta-ketothiolase Deficiency: The First Report from Iran and Review of Literature.

    Vakili R, Hashemian S

    Iranian journal of child neurology 2018; (12(3)):113-121.

    PMID: 30026775
  13. 13

    Unexplained Tachypneoa and Severe Metabolic Acidosis in a Three-Month-Old Child: A Rare Presentation of Beta-Ketothiolose Deficiency.

    Thadchanamoorthy V, Dayasiri K

    Cureus 2022; (14(2)):e21934 doi:10.7759/cureus.21934.

    PMID: 35273875
  14. 14

    Mitochondrial acetoacetyl-CoA thiolase deficiency: basal ganglia impairment may occur independently of ketoacidosis.

    Paquay S, Bourillon A, Pichard S, et al.

    Journal of inherited metabolic disease 2017; (40(3)):415-422 doi:10.1007/s10545-017-0021-y.

    PMID: 28255778
  15. 15

    Ketoacidotic crisis after vaccination in a girl with beta-ketothiolase deficiency: a case report.

    Mao S, Yang L, Yin X, et al.

    Translational pediatrics 2021; (10(2)):459-463 doi:10.21037/tp-20-265.

    PMID: 33708533
  16. 16

    Beta-ketothiolase deficiency: A case with unusual presentation of nonketotic hypoglycemic episodes due to coexistent probable secondary carnitine deficiency.

    Alijanpour M, Sasai H, Abdelkreem E, et al.

    JIMD reports 2019; (46(1)):23-27 doi:10.1002/jmd2.12022.

    PMID: 31240151
  17. 17

    Longitudinal biochemical profiles in beta-ketothiolase deficiency: Phase-dependent diagnostic challenges and metabolic variability.

    Ergun NÜ, Coşkun N, Aslantaş M, Köse MAK

    Molecular genetics and metabolism 2026; (149(1-2)):110244 doi:10.1016/j.ymgme.2026.110244.

    PMID: 42659719

This page is for informational purposes only and does not replace professional medical advice. It explains general beta-ketothiolase deficiency management, but your child's metabolic team should provide the individualized fasting and illness plan.